Marco Londei, Chief Medical Officer at ANAPTYSBIO INC (ANAB), sold 60,096 shares at $66.38 ($4.0M) on 2018-12-17, disclosed to the SEC on 2018-12-18.
Open-market sale of $4.0M ANAB by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.36 | 12,120 | $792K | 19.7% |
| 2 | $65.36 | 12,120 | $792K | 19.7% |
| 3 | $66.38 | 3,185 | $211K | 5.3% |
| 4 | $66.38 | 3,185 | $211K | 5.3% |
| 5 | $67.57 | 8,002 | $541K | 13.5% |
| 6 | $67.57 | 8,002 |
| $541K |
| 13.5% |
| 7 | $68.47 | 6,741 | $462K | 11.5% |
| 8 | $68.47 | 6,741 | $462K | 11.5% |
| Total | $66.75 avg | 60,096 | $4.0M | 100% |
| Filing → |